Rob Gietl, MYM Nutraceuticals CEO focus on Cannabis Consumables Facility
Rob Gietl, CEO of MYM Nutraceuticals, focus cannabis company in the medical industry.
About MYM Nutraceuticals
MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end medicinal cannabis supplements and topical products.
The company also has interest in two international cannabis production projects in Australia and Colombia.
In New South Wales, Australia, the “Northern Rivers Project” have 1.2 million square feet of cannabis production space.
In Medellin, Colombia, MYM and Colombia Organica are planning to build a cannabis production facility in the region.
Furthersome, Colombia Organica is in the licensing process for the cultivation and production of high-THC cannabis extracts.
To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors.
MYM through its various joint ventures is currently building three large-scale production facilities in both Canada and Australia.
As a result, upon completion of these three projects, the total amount of greenhouse growing space is expected to exceed 2.7 million square feet.
For more information on MYM Nutraceuticals (MYM:CSE) please fill out the form below.